58 results
8-K
EX-99.2
VIR
Vir Biotechnology Inc
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
, if approved, is also subject to approval. Obtaining approval for our product candidates in the European Union, or EU, from the European Commission … the exit of the United Kingdom from the European Union may be a source of instability in international markets, create significant currency fluctuations
8-K
EX-99.1
VIR
Vir Biotechnology Inc
25 Mar 22
Other Events
4:10pm
to sotrovimab
Sotrovimab is authorized for emergency use in the United States and has been granted a marketing authorization in the European Union (EU
8-K
EX-99.2
1ykgbwu
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm
DRS
EX-10.54
2mevw4u
23 Jun 20
Draft registration statement
12:00am
8-K
EX-99.1
anvki tkjt4wu3u
4 Nov 21
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:07pm
8-K
EX-99.1
gqysk2ny9 px5lj2d9
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
DRS
EX-10.53
l09pz 4a43va
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.56
y4tisnm
23 Jun 20
Draft registration statement
12:00am
8-K
EX-99.1
wxizz
5 Aug 21
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results
4:14pm
10-K
gqd5376rki uvlrwu
26 Mar 20
Annual report
4:08pm